ECAT's strategy includes a significant focus on technology, financials, and healthcare. Read why ECAT CEF is a compelling buy ...

O, with a diversified tenant base, offers solid growth and dividends. But will tariffs, inflation and high rates impact its ...

Despite Q4 earnings hit by transaction costs, CBIZ expects smoother progress and significant growth in 2025. See why I ...

"Markets fixate on one risk at a time, and there's no shortage right now. Volatility has spiked, liquidity is thin, and ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A ...

Living alone often means much higher costs. A new study identifies the best places for singles considering to relocate with ...

AGNC Investment ( AGNC 1.26%) has an eye-catching dividend yield of almost 14%. The first thing that most investors will ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

Columnist Teri Sforza writes that a state watchdog is the latest to begin hearings on ‘urgent policy dilemma.’ ...

Additionally, Nasdaq recently removed the requirement for public companies to publish a board diversity matrix, and ISS, ...

Following the company’s fourth quarter results, Desjardins analyst Jerome Dubreuil has raised his price target on Quebecor.

The shares of Sbi Life Insurance Company closed 2.73% down on Friday at Rs 1,429.65 a share, with a market value of Rs ...